Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Studies from J.A.R. Carr and co-researchers update current data on addiction medicine
July 1st, 2009
In this recent study, researchers in London, Canada conducted a study "To determine the incidence of concurrent substance misuse among individuals entering first-episode psychosis treatment, and examine whether patients with concurrent substance misuse differ on variables relevant to service planning. Consecutive patients (n = 376) were assessed using standardized instruments." "Twenty-two per cent met abuse or dependence criteria for a single substance, and 8% met criteria for two substances. Most met criteria for marijuana or marijuana and alcohol. The majority of patients with a concurrent disorder were male, and on average they were 3.5 years younger at psychosis...
Source: Biotech Week (2009-07-01)
|
